Citations

Clear

626 citation(s) found for "Mehta, SH".

We Restrict CRRT to Only the Most Hemodynamically Unstable Patients
Mehta, Ravindra L. , Kashani, Kianoush , Mehta, Ravindra L

Mayo Clinic

Seminars in Dialysis | April 13, 2016 | Volume: 29 | Issue: 4 | Pages: 268-271

10.1111/sdi.12507 | PMID 27074128 Get It

AbstractFrom the initial version of an extended renal replacement therapy, the initiative to provide safer, more efficient means for detoxification and volume removal in comparison with intermittent renal replacement therapies (IRRT) has been evaluated. As a result, the Kidney Disease Improving Global Outcomes guidelines for acute kidney injury recommend the preferential use of continuous renal replacement therapy (CRRT) in patients who are hemodynamically unstable or who suffer from intracranial hypertension. The choice of dialysis modality is also influenced by other factors including clinical expertise, and the availability of each treatment option in individual medical centers. In the scientific community, there is an ongoing debate regarding the choice of dialysis modality. On one side, the inability of recent studies to demonstrate any mortality or renal recovery benefit for CRRT, the need for patient immobilization, and prohibitive additional costs impede widespread adoption of the method.On the other side, the physiological advantages of CRRT in detoxification and volume removal and the identified flaws related to the comparative literature regarding CRRT and IRRT fuel this debate. Fluid overload is a recognized and yet clinically underappreciated factor that increases morbidity and mortality in the intensive care unit (ICU). Continuous renal replacement therapy has a distinct advantage over IRRT in achieving euvolemia and thus the potential for improving outcomes in all patients in the ICU setting in which extensive fluid administration is often obligatory. With this in mind, perhaps CRRT should not be restricted to only those patients in whom their hemodynamic status requires it. This article reviews the current literature and the myths that may influence the selection of one mode of therapy over the other among patients requiring renal replacement therapy in the ICU.
Thermal Ablative Therapies and Immune Checkpoint Modulation: Can Locoregional Approaches Effect a Systemic Response?
Mehta, Amol , Öklü, Rahmi , Sheth, Rahul A. , Oklu, Rahmi

Mayo Clinic

Gastroenterology Research and Practice | March 9, 2016 | Volume: 2016 | Issue: No issue available | Pages: 1-11

10.1155/2016/9251375 | PMID 27051417 Get It

Percutaneous image-guided ablation is an increasingly common treatment for a multitude of solid organ malignancies. While historically these techniques have been restricted to the management of small, unresectable tumors, there is an expanding appreciation for the systemic effects these locoregional interventions can cause. In this review, we summarize the mechanisms of action for the most common thermal ablation modalities and highlight the key advances in knowledge regarding the interactions between thermal ablation and the immune system.
Low Gleason Architectural Pattern in Prostate Carcinoma: A Possible Function of Nodular Stromal Hyperplasia?
Mehta, Vikas , Barkan, Güliz A. , Jiménez, Rafael E. , Paner, Gladell P.

Mayo Clinic

American Journal of Clinical Pathology | February 16, 2016 | Volume: 138 | Issue: suppl_1 | Pages: A347-A347

10.1093/ajcp/138.suppl1.323 Get It

Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings
Dugger, Brittany N. , Hentz, Joseph G. , Hinni, Michael L., Driver‐Dunckley, Erika , Mehta, Shyamal, Sue, Lucia I., Duffy, Amy, Intorcia, Anthony J., Filon, Jessica, Pullen, Joel, Walker, Douglas G. , Beach, Thomas G. , Driver-Dunckley, Erika, Adler, Charles H. , Lott, David G. , Mehta, Shyamal H. , Serrano, Geidy E. , Dugger, Brittany N

Mayo Clinic

Movement Disorders | January 22, 2016 | Volume: 31 | Issue: 2 | Pages: 250-256

10.1002/mds.26476 | PMID 26799362 Get It

ABSTRACTIntroductionFinding a peripheral tissue biopsy site to diagnose early PD would be of value for clinical care, biomarker validation, and as research enrollment criteria. Whereas autopsy and advanced PD studies suggest that the submandibular gland is an important biopsy site, there are no studies in early PD. The aim of this study was to determine whether needle biopsy of the submandibular gland reveals Lewy type alpha‐synucleinopathy in early PD.MethodsTwenty‐five early PD (duration < 5 years) and 10 controls underwent transcutaneous needle core biopsies of the submandibular gland. Tissue was stained for phosphorylated alpha‐synuclein, reviewed blind to clinical diagnosis, and only nerve element staining was considered positive.ResultsMean (standard deviation) age was 69.5 (8.3) for the PD group, 64.8 (8.0) years for controls, and disease duration 2.6 (1.1) years. Six PD and 1 control subject had inadequate glandular tissue. Positive staining was found in 14 of 19 (74%) PD and 2 of 9 (22%) control subjects. PD‐positive and ‐negative cases did not differ clinically. Adverse events (mainly swelling and bruising) were common (77% of cases), but were minor and transient.ConclusionsSubmandibular gland needle biopsies identified phosphorylated alpha‐synuclein staining in 74% of early PD subjects. False positives may be true false positives or may represent prodromal PD. If confirmed in larger studies with eventual autopsy confirmation, the potential value of submandibular gland biopsies for early PD may be to aid in clinical trial inclusion/exclusion and eventually serve as a gold standard for biomarker studies short of autopsy confirmation. © 2016 International Parkinson and Movement Disorder Society
Simplified conversion method for unified Parkinson's disease rating scale motor examinations
Hentz, Joseph G. , Mehta, Shyamal H. , Shill, Holly A. , Driver‐Dunckley, Erika, Beach, Thomas G. , Driver‐Dunckley, Erika , Adler, Charles H.

Mayo Clinic

Movement Disorders | November 17, 2015 | Volume: 30 | Issue: 14 | Pages: 1967-1970

10.1002/mds.26435 | PMID 26779608 Get It

ABSTRACTBackgroundWe evaluated a simplified method for converting Unified Parkinson's Disease Rating Scale Part III Motor Examination total scores (UPDRS III) to the International Parkinson and Movement Disorder Society's (MDS) revised version of the scores.MethodsPD patients in the Arizona Study of Aging and Neurodegenerative Disorders were assessed with both scales. The accuracy of the predicted scores was assessed using regression modeling, classical intraclass correlation coefficients, and the Bland‐Altman method.ResultsThere was strong correlation between the two scores. Adding 7 points to a UPDRS III total score performed approximately as well as previously published conversion formulas (intraclass correlation: 0.96). The adjusted score is expected to be within 3 points of the MDS‐UPDRS III score 50% of the time and within 9 points 95% of the time.ConclusionsSimply adding 7 points to a UPDRS III total score provides a good approximation of the MDS‐UPDRS III total score. © 2015 International Parkinson and Movement Disorder Society
Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts
Caviness, John N., Utianski, Rene L. , Hentz, Joseph G. , Beach, Thomas G. , Dugger, Brittany N. , Shill, Holly A. , Driver‐Dunckley, E. D., Mehta, Shyamal H. , Driver‐Dunckley, Erika , Sabbagh, Marwan Noel , Adler, Charles H. , Utianski, Rene L , Dugger, Brittany N

Mayo Clinic

European Journal of Neurology | October 31, 2015 | Volume: 23 | Issue: 2 | Pages: 387-392

10.1111/ene.12878 | PMID 26518336 Get It

Background and purposeIt is believed that progressive Lewy‐type synucleinopathy (LTS) is primarily responsible for the worsening of motor and non‐motor Parkinson's disease (PD) signs and symptoms. Characterization of quantitative electroencephalography (QEEG) abnormalities across the spectrum of LTS to PD dementia (PD‐D) may provide insight into the pathophysiology of PD cortical dysfunction. Here our enlarged EEG database was leveraged to characterize spectral QEEG abnormalities in asymptomatic autopsy‐defined groups of control participants and incidental Lewy body disease (ILBD) and three clinically defined groups of participants with PD (cognitively normal PD, mild cognitive impairment PD, and PD‐D).MethodsThe PD cohort was studied as part of the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND). AZSAND utilizes its Brain and Body Donation Program to perform prospective, standardized, regular longitudinal pre‐mortem assessments until death. Resting EEG from subjects was analyzed for spectral domain QEEG measures of background rhythm frequency and global relative power in delta, theta, alpha and beta bands.ResultsThe various spectral QEEG measures showed differential changes specific to the groups compared. Important findings were background rhythm frequency showing the most pairwise differences across the groups, and this also was the only significant difference between control and ILBD. An increase in delta bandpower was characteristic of worsening cognitive deficits.ConclusionsDifferent patterns of change amongst QEEG measures across LTS and PD cognitive states suggest that they correlate with heterogeneous pathophysiologies of cortical dysfunction within the PD clinical spectrum. In addition, the biomarker application of a specific spectral QEEG measure needs to be selectively suited to its study purpose.
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer
Zhang, Yaqin , Mehta, Amit, Boufraqech, Myriem , Tian, Ze , Yu, Zhiya , Boxer, Matthew B., Kiefer, Jeffrey , Copland, John A. , Smallridge, Robert C., Li, Zhuyin, Kebebew, Electron , Zhang, Lisa M. , Davis, Sean , Wang, Jing , Shen, Min

Mayo Clinic

Oncotarget | September 15, 2015 | Volume: 6 | Issue: 11 | Pages: 9073-9085

10.18632/oncotarget.3268 | PMID 25940539 Get It

Palmar-plantar erythrodysesthesia
Khanna, Sahil , Gupta, Arjun , Mehta, Anurag

Mayo Clinic

BMJ Case Reports | September 10, 2015 | Volume: 2015 | Issue: No issue available | Pages: bcr2015212434

10.1136/bcr-2015-212434 | PMID 26359464 Get It

Abstract 4629: Multiple myeloma susceptibility loci examined in African and European ancestry populations
Rand, Kristin A. , Song, Chi , Déan, Eric, Serie, Daniel, Curtin, Karen , Hazelett, Dennis J. , Hwang, Amie E. , Sheng, Xin , Stram, Alex , Huff, Carol Ann , Bernal‐Mizrachi, Leon , Roos, Anneclaire De, Pawlish, Karen , Peters, Edward , Bock, Catherine, Conti, David V. , Zimmerman, Todd M., Huntsman, Scott , Graff, John, Mehta, Jayesh, Janakiraman, Nalini, Severson, Richard K., Brown, Elizabeth E. , Kolonel, Laurence N. , Henderson, Brian E., Spinelli, John J., Zonder, Jeffrey A. , Camp, Nicola J. , Vachon, Celine M. , Stram, D. O., Haiman, Christopher A. , Berg, David Van Den , Tomasson, Michael H. , Ailawadhi, Sikander , Singhal, Seema , Colditz, Graham A. , Chanock, Stephen Jacob , Lieber, Michael R. , Klein, Eric A. , Brooks‐Wilson, Angela , Rajkumar, S. Vincent , Slager, Susan L. , Giles, Graham G. , Chiu, Brian C.‐H. , Anderson, Kenneth C. , Orlowski, Robert Z. , Lonial, Sagar , Vachon, Celine M. , Ziv, Elad , Cozen, Wendy , Hazelett, Dennis J , Conti, David V

Mayo Clinic

Cancer Research | August 5, 2015 | Volume: 75 | Issue: 15_Supplement | Pages: 4629-4629

10.1158/1538-7445.am2015-4629 Get It

Abstract Genome-wide association studies (GWAS) of multiple myeloma (MM) in Northern Europeans have identified seven novel risk loci (2p23.3, 3p22.1, 3q26.2, 6p21.33, 7p15.3, 17p11.2, 22q13.1). We performed a multiethnic meta-analysis of these regions in 1,274 MM patients and 1,486 controls of European ancestry (EA) and 1,049 MM patients and 7,080 controls of African ancestry (AA), leveraging the differential linkage-disequilibrium of these populations in order to better localize the putative functional variants. We observed directionally consistent effects for all seven index SNPs in both populations, with four significantly associated (p&lt;0.05) with risk in EAs (3p22.1, 7p15.3, 17p11.2, 22q13.1), and two significantly associated with risk in AAs (7p15.3 and 22q13.1). In a fixed effects meta-analysis of six regions (excluding the HLA region on chromosome 6), variation in five of the regions (2p33.3, 3p22.1, 7p15.3, 17p11.2, 22q13.1) had statistically significant associations with risk (Table 1). In one region, the index variant had the strongest association [rs4487645 at 7p15.3, (OR = 1.30, p = 8.7×10−8)]. Five of the six most significantly associated variants identified in the multiethnic analyses overlapped with biologically relevant features indicating regulatory activity based on CD20+ (B lymphocyte) cells, showing evidence of potential function; those included a missense variant in (17p11.2, rs34562254, Pro251Leu) in TNFRSF13B, which encodes a lymphocyte-specific protein in the tumor necrosis factor receptor family that interacts with the NF-kb pathway. Our study shows that these regions are important in MM risk across ethnicities and further supports the use of multiple ethnic groups in genetic studies to enhance identification of risk variants. Table 1.Most significant associations for each region in the multiethnic meta-analysis.Individuals of European AncestryIndividuals of African AncestryMulitethnic Metar2 with IndexcCHRSNPRAaFreqbORP-valueFreqbORP-valueORP-valueP-het2rs732075G0.591.222.0×10−30.621.122.0×10−21.162.6×10−40.280.09/0.283rs73069394A0.191.243.0×10−30.621.181.5×10−21.201.3×10−50.550.77/0.963rs12637184G0.761.136.0×10−20.921.192.7×10−11.151.0×10−20.640.94/1.007rs4487645C0.671.237.0×10−40.891.485.5×10−51.308.7×10−80.07-d17rs34562254A0.121.452.4×10−50.131.212.2×10−31.312.5×10−60.120.33/0.9022rs139400T0.491.224.0×10−40.531.172.1×10−31.191.2×10−60.630.63/0.96aRisk allelebFrequency of the risk allele in European and African ancestry studiescr2 metrics based on 1000 Genomes Project AFR/EUR populationsdIndex SNP Citation Format: Kristin A. Rand, Chi Song, Eric Dean, Daniel Serie, Karen Curtin, Dennis Hazelett, Amie E. Hwang, Xin Sheng, Alex Stram, David J. Van Den Berg, Carol Ann Huff, Leon Bernal-Mizrachi, Michael H. Tomasson, Sikander Ailawadhi, Anneclaire De Roos, Seema Singhal, Karen Pawlish, Edward Peters, Catherine Bock, David V. Conti, Graham Colditz, Todd Zimmerman, Scott Huntsman, John Graff, African Ancestry Prostate Cancer GWAS Consortium,African Ancestry Breast Cancer GWAS Consortium, Stephen J. Chanock, Michael Lieber, Jayesh Mehta, Eric A. Klein, Nalini Janakiraman, Richard K. Severson, Angela R. Brooks-Wilson, Vincent Rajkumar, Elizabeth E. Brown, Laurence Kolonel, Susan Slager, Brian E. Henderson, Graham G. Giles, John J. Spinelli, Brian Chiu, Kenneth C. Anderson, Jeffrey Zonder, Robert Z. Orlowski, Sagar Lonial, Nicola Camp, Celine Vachon, Elad Ziv, Dan O. Stram, Christopher A. Haiman, Wendy Cozen. Multiple myeloma susceptibility loci examined in African and European ancestry populations. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 4629. doi:10.1158/1538-7445.AM2015-4629